Mustang Bio receives Nasdaq delisting notice for failure to meet equity requirement

MUSTANG BIO, INC.

Nasdaq Staff determined to delist MBIO due to non-compliance with $2.5M stockholders' equity requirement by Sept 9, 2024 extension deadline.
Company intends to request a hearing before Nasdaq Hearings Panel, which will stay delisting pending hearing and any granted extension.
Trading on Nasdaq Capital Market under symbol MBIO continues pending the hearing process.
No assurance that Panel will grant continued listing or that compliance can be shown within any extension period.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.